Invivyd expects to advance VBY329 toward IND readiness in 2H 2026 for development in pediatric RSV prophylaxis, a blockbuster pharmaceutical market in 2024, expected to grow to $3-$4 billion in annual ...

Japan’s first domestically produced vaccine for the virus that causes COVID-19 has been cleared for regulatory approval.

TOKYO - The Japanese government on Thursday is set to announce that the current COVID-19 quasi-emergency measures in place ...

An antiviral pill has, for the first time, been shown to prevent COVID-19 in people exposed to the SARS-CoV-2 virus at home, according to trial results published today in the New England Journal of ...

Doctors say the number of vaccinated mothers remains too low to show a measurable dip in infant hospitalisations.

SARS-CoV-2, the virus responsible for COVID-19, is widespread among wildlife species, according to new research. The virus was detected in six common backyard species, and antibodies indicating prior ...

Almost as soon as the hantavirus outbreak on the cruise ship MV Hondius became international news, public health experts ...

The first suspected 'generation-three' hantavirus case has emerged, potentially signifying the first stage of a wider ...

Scientists warn hantavirus may be as contagious as Covid as they identify 19 May as the critical date to discover whether the ...

May 19 could prove critical in the hantavirus outbreak. Currently, no cases have been confirmed in people who were not on ...